SCHEMBL14014167

SCHEMBL14014167

CSc1ncc2cc(Oc3ccc(F)cc3)c(=O)n(C)c2n1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 15/20 0.57
MAPK8 P45983 8/20 0.49
RPS6KA4 O75676 2/20 0.45
MAPK9 P45984 2/20 0.45
RPS6KA3 P51812 2/20 0.45
MAPK10 P53779 2/20 0.45
MAPK11 Q15759 2/20 0.45
NLK Q9UBE8 2/20 0.45
CSNK1E P49674 1/20 0.45
GAK O14976 1/20 0.44
PRKD3 O94806 1/20 0.44
MAP4K4 O95819 1/20 0.44
MAPK1 P28482 1/20 0.44
CSNK1D P48730 1/20 0.44
DDR1 Q08345 1/20 0.44
TAOK1 Q7L7X3 1/20 0.44
COQ8A Q8NI60 1/20 0.44
PRKD2 Q9BZL6 1/20 0.44
STK36 Q9NRP7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5121344 0.88 MAPK14 (0.46) MAPK14MAPK8
SCHEMBL14014073 0.88 MAPK14 (0.56) MAPK14MAPK8MAPK1
SCHEMBL5110207 0.88 MAPK14 (0.59) MAPK14MAPK8RPS6KA4MAPK9RPS6KA3
SCHEMBL14014195 0.87 MAPK14 (0.54) MAPK14MAPK8RPS6KA4MAPK9RPS6KA3
SCHEMBL29830087 0.86 MAPK14 (0.70) MAPK14MAPK8RPS6KA4MAPK9RPS6KA3
SCHEMBL14014098 0.86 MAPK14 (0.70) MAPK14MAPK8RPS6KA4MAPK9RPS6KA3
SCHEMBL14627366 0.85 MAPK14 (0.43) MAPK14MAPK8RPS6KA4MAPK9RPS6KA3
SCHEMBL14014464 0.85 MAPK14 (0.57) MAPK14MAPK8RPS6KA4MAPK9RPS6KA3
SCHEMBL5107331 0.85 MAPK14 (0.58) MAPK14MAPK8RPS6KA4MAPK9RPS6KA3
SCHEMBL14038757 0.83 MAPK14 (0.59) MAPK14MAPK8RPS6KA4MAPK9RPS6KA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449581-B2 6-Substituted pyrido-pyrimidines POCHE PALO ALTO LLC (US) 2008-11-11 US disclosed
US-20070135458-A1 6-Substituted pyrido-pyrimidines CHEN JIAN J 2007-06-14 US disclosed
US-20070135458-A1 6-Substituted pyrido-pyrimidines CHEN JIAN J 2007-06-14 US disclosed
US-7169794-B2 6-substituted pyrido-pyrimidines ROCHE PALO ALTO LLC (US) 2007-01-30 US disclosed
US-7169794-B2 6-substituted pyrido-pyrimidines ROCHE PALO ALTO LLC (US) 2007-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135458-A1 6-Substituted pyrido-pyrimidines P2RX6, P2RX1, P2RX7 MAPK14 4250/4885MAPK8 3523/4885RPS6KA4 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.